Skip to main content
. 2017 Mar 27;7:45311. doi: 10.1038/srep45311

Figure 7. C9ORF135 is downregulated in response to hESC differentiation.

Figure 7

(a) Morphology and (b) western blot analysis of hESC clones after C9ORF135 knockdown or treatment with RA. (c) Immunofluorescence analysis of C9ORF135 and neural cell markers TUBB3 and MAP2 in differentiated hESCs.

HHS Vulnerability Disclosure